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SUMMARY
Activation of the NLRP3 inflammasome by Leish-
mania parasites is critical for the outcome of leish-
maniasis, a disease that affects millions of people
worldwide. We investigate the mechanisms involved
in NLRP3 activation and demonstrate that caspase-
11 (CASP11) is activated in response to infection by
Leishmania species and triggers the non-canonical
activation of NLRP3. This process accounts for
host resistance to infection in macrophages and
in vivo. We identify the parasite membrane glycocon-
jugate lipophosphoglycan (LPG) as the molecule
involved in CASP11 activation. Cytosolic delivery of
LPG in macrophages triggers CASP11 activation,
and infections performed with Lpg1–/– parasites
reduce CASP11/NLRP3 activation. Unlike bacterial
LPS, purified LPG does not activate mouse
CASP11 (or human Casp4) in vitro, suggesting the
participation of additional molecules for LPG-medi-
ated CASP11 activation. Our data identify a parasite
molecule involved in CASP11 activation, thereby es-
tablishing the mechanisms underlying inflamma-
some activation in response to Leishmania species.
INTRODUCTION
Leishmaniasis is a chronic inflammatory disease caused by the
protozoan parasite of the Leishmania genus. The disease is wide-
spread in tropical and subtropical areas of the globe, including Eu-
rope, Africa, Asia, and the Americas, and affectsmillions of people
(Alvar et al., 2012). Species such as Leishmania (Leishmania) am-
azonensis and L. (Viannia) braziliensis induce cutaneous leishman-
iasis, which manifests as a localized form of the disease and can
progress to more severe forms, such as diffuse and mucocuta-
neous, respectively. In contrast, L. (L.) infantum causes a life-
threatening visceral form of leishmaniasis (Chappuis et al., 2007;
Reithinger et al., 2007). It is estimated that 350 million people
are at risk, and more than 2 million new cases appear every
year. Most infected people are asymptomatic, whereas 12 million
patients have active disease, and 20,000–50,000 eventually die
(Alvar et al., 2012; World Health Organization, 2010).
Leishmania spp. interact withmany cell types, including neutro-
phils, monocytes, andmacrophages, where they differentiate into
amastigotes and replicate inside the parasitophorous vacuole.
Innate immune receptors present in these professional phago-
cytes are critical for initiating an effective and protective immune
response against the disease (Kaye and Scott, 2011; Zamboni
and Lima-Junior, 2015). Recent studies have indicated that intra-
cellular receptors from the family of the nucleotide-bindingdomain
and leucine-rich repeat-containing proteins (NLRs) are critical for
the outcome of leishmaniasis (Charmoy et al., 2016; Gurung
et al., 2015; Lima-Junior et al., 2013, 2017). NLRP3 is the most
studied NLR; it is associated with the pathogenesis of several in-
flammatory diseases and is also involved in the sensing and re-
striction of infection by severalmicroorganisms, including bacteria
and parasites (reviewed in Broz and Dixit, 2016; Zamboni and
Lima-Junior, 2015). A wide variety of stimuli, such as toxins, crys-
tals, ATP, cathepsins, and reactive oxygen species (ROS), have
been shown to trigger the canonical NLRP3 inflammasome, but
NLRP3 can also be activated via murine caspase-11 (CASP11;
anorthologof humanCasp4andCasp5),which recognizes bacte-
rial lipopolysaccharide (LPS) in the cytoplasm and induces the
non-canonical activation of the NLRP3 inflammasome (Hagar
et al., 2013; Kayagaki et al., 2013; Shi et al., 2014).
Although LPS is the major glycolipid present in Gram-negative
bacteria, lipophosphoglycan (LPG) is the major glycoconjugate
present on the surface of Leishmania parasites (reviewed in
Turco and Descoteaux, 1992). LPG has been implicated in cyto-
kine production via Toll-like receptors (TLRs), attachment and
entry into macrophages, inhibition of phagosomal maturation,
protection from proteolytic damage within acidic vacuoles, and
induction of neutrophil extracellular traps (reviewed in de Assis
et al., 2012; Franco et al., 2012; Matte and Descoteaux, 2016).
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This molecule is predominantly expressed in promastigotes, and
its synthesis is highly downregulated after differentiation in
amastigotes (Turco and Descoteaux, 1992).
The NLRP3 inflammasome was shown to be triggered by mul-
tiple species of Leishmania (Charmoy et al., 2016; Dey et al.,
2018; Gurung et al., 2015; Lefe`vre et al., 2013; Lima-Junior
et al., 2013), but little is known regarding the signaling pathways
that lead to NLRP3 activation in response to Leishmania. Here,
we found that CASP11 plays an important role in NLRP3 activa-
tion and accounts for the inflammasome-mediated restriction of
parasite infection. We identified Leishmania LPG as an activator
of CASP11. Unlike LPS, the LPG-mediated activation of CASP11
is indirect, suggesting the requirement of additional molecules/
receptors to allow LPG-mediated activation of CASP11.
RESULTS
CASP11 Contributes to the Control of Leishmania spp.
Replication in Macrophages and In Vivo
CASP11 has been implicated in the non-canonical activation
of NLRP3; therefore, we investigated whether CASP11 plays a
role in the NLRP3-mediated restriction of Leishmania infection.
Bone marrow-derived macrophages (BMDMs) from C57BL/6
(wild-type [WT]), Nlrp3–/–, or Casp11–/– mice were infected with
metacyclic promastigotes of Leishmania at an MOI of 1. Internal-
ization and intracellular parasite loads were determined by Gi-
emsa staining or fluorescence-activated cell sorting (FACS).
Although NLRP3 and CASP11 deficiency did not affect inter-
nalization of the parasites after 1 hr of infection, it affected intra-
cellular parasite load after 48 or 96 hr. This was observed using
many species of Leishmania: L. major (L.m.; Figures 1A and 1B),
L. braziliensis (L.b.; Figures 1C and 1D), and L. amazonensis (L.a.;
Figures 1E and 1F). To further assess the importance of CASP11
for the restriction of Leishmania replication in macrophages, we
used a strain of L. amazonensis expressing GFP and performed
flow cytometry using different MOIs (1, 5, and 10). We observed
that the parasite loadswere higher inNlrp3–/– andCasp11–/– cells
compared with WT cells, as shown by the percentage of GFP+
cells (Figures 1G, 1I, and 1K) and the integrated mean fluores-
cence intensity (iMFI; Figures 1H, 1J, and 1L). The flow cytometry
gating strategy, uninfected cells, and non-GFP-expressing
Leishmania are shown (Figure S1A). We have previously shown
Figure 1. Caspase-11 Is Important for Con-
trolling Leishmania spp. Infection In Vitro
and In Vivo
(A–L) C57BL/6, Nlrp3–/–, and Casp11–/– BMDMs
were infected with metacyclic promastigotes from
L. major (A and B), L. braziliensis (C and D), and
L. amazonensis (E and F) at an MOI of 1 or different
MOIs of stationary-phase promastigotes from
L. amazonensis-GFP+ (L.a.-GFP+) (G–L) for 1 hr,
washed, and incubated for 48 and 96 hr. Cells
infected with L. amazonensis GFP+ at MOI 1
(G and H), MOI 5 (I and J), or MOI 10 (K and L) were
detached from plates and analyzed by FACS. The
percentage of infected cells and the average
number of parasites per cell were determined by
Giemsa staining (A–F). In (A)–(F), pound sign
indicates statistical difference of 48 or 96 hr
compared with 1 hr group of the same genotype.
The percentage of L. amazonensis-GFP+ cells and
the integrated mean fluorescence intensity (iMFI)
of GFP-expressing parasites were quantified using
flow cytometry.
(M–O) C57BL/6, Nlrp3–/–, and Casp11–/– mice
(n = 5 mice per group) were infected with 103
metacyclic L. amazonensis promastigotes in the
ear, and the ear thicknesses were followed
for 15 weeks (M). Images of infected ears (N)
and parasite quantification (O) at 15 weeks
post-infection.
The data are represented as the mean ± SD of
triplicate samples and are representative of the
data obtained from three (A–F) or two (G–O) inde-
pendent experiments. Statistical analysis was
performed using Student’s t test (A–L and O) or
two-way ANOVA with Bonferroni’s multiple-com-
parison test (M). Asterisks indicate significant dif-
ferences (p < 0.05) between indicated groups and
WT BMDMs (A–L and O), whereas asterisk and
ampersand (M) indicate differences between
C57BL/6 andCasp11–/–, orCasp11–/–, andNlrp3–/–
mice, respectively.
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that NLRP3-mediated restriction of L. amazonensis replication in
macrophages involves upregulation of NOS2 (Lima-Junior et al.,
2013). Thus, we tested if CASP11 affected NOS2 expression in
response to infection and found a defective upregulation of
NOS2 in Casp11–/– and Nlrp3–/– BMDMs infected with
L. amazonensis (Figure S1B). In support of our data indicating
that ROS is upstream of inflammasome activation (Lima-Junior
et al., 2017), we found that ROS production was independent
of CASP11 and NLRP3 (Figure S1C). To test if the CASP11 phe-
notypes were caused by defective NLRP3 expression, we
measured NLRP3 expression in Casp11–/– macrophages and
found normal NLRP3 expression (Figure S1D).
Next, we used Nlrp3–/– and Casp11–/– mice to assess the
physiological relevance of this pathway for host resistance
in vivo. WT, Nlrp3–/–, and Casp11–/– mice were intradermally in-
fected in the ear with 103 metacyclic promastigotes of
L. amazonensis, and the infection was monitored for 15 weeks.
We found that Casp11–/– mice were more susceptible to the
disease, as observed by increased ear thickness after the 5th
week of infection, similar to that observed in Nlrp3–/– mice (Fig-
ure 1M). After the 12th week of infection, the lesions in the ears
of Casp11–/– mice stabilized and were statistically different from
those formed in the C57BL/6 and Nlrp3–/– mice. Images of the
infected ears in the 15th week of infection illustrate the lesion
development (Figure 1N), and we found that CASP11 and
Figure 2. Leishmania spp. Trigger Non-
canonical Inflammasome Activation in
Macrophages
(A–C) Primed BMDMs were infected with station-
ary-phase L. amazonensis promastigotes at an
MOI of 10. The levels of IL-1b (A and C) and TNF-a
(B) were measured using ELISA.
(D–G) C57BL/6, Nlrp3–/–, and Casp11–/–
BMDMs were stained with FAM-YVAD after
L. amazonensis infection at an MOI of 10, and the
percentages of active CASP1-positive cells (E)
and the integrated mean fluorescence intensity
(iMFI) (F) were evaluated. A representative histo-
gram is shown (D). Cells were infected with
L. amazonensis (L.a) (G), and CASP1 levels were
measured in the supernatants using ELISA.
(H) PAM(3)CSK(4)-primed (300 ng mL1) BMDMs
were pre-treated with biotin-VAD-FMK and in-
fected with different Leishmania species (MOI 10)
or L. pneumophila flaA (positive control). Immu-
noblotting shows the presence of CASP11 p45
and p38 in the cell lysate (input) and pull-down
fractions, representative of activated CASP11.
Actin (b-actin) was used as a loading control.
The data are represented as the mean ± SD of
triplicate samples (A–I) and are representative of
the data obtained from three (A–C) and two (D–H)
independent experiments that yielded similar re-
sults. Statistical analysis was performed using
Student’s t test. Asterisks indicate statistically
significant differences. *p < 0.05.
NLRP3 deficiency resulted in increased
parasite loads in the infected ears (Fig-
ure 1O). Similar results were obtained
when mice were infected with 106 stationary-phase promasti-
gotes of L. amazonensis (Figures S1E and S1F). Next, we
measured activation of the inflammasome in vivo in the ears
of mice infected with L. amazonensis. We detected CASP1 in
the ears of the infected mice in the ears of the infected mice,
and this process was partially dependent on NLRP3 and
CASP11 (Figure S1G).
CASP11 Is Activated during Leishmania spp. Infection
and Accounts for CASP1 Activation and IL-1b Induction
To evaluate if CASP11 contributes to the non-canonical activa-
tion of NLRP3, we infected WT, Nlrp3–/–, and Casp11–/– BMDMs
with L. amazonensis and quantified IL-1b production. While
NLRP3 deficiency abrogated IL-1b production, Casp11–/– cells
had significantly decreased IL-1b secretion (Figures 2A, S2A,
and S2B), but not TNF-a (Figure 2B). Intracellular LPS triggers
CASP11 activation; thus, we used TNF-a (Figure 2C) or PAM(3)
CSK(4) for priming (Figure S2A) and obtained similar results.
Our data indicate that in endotoxin-free conditions, CASP11 is
also required for efficient activation of the NLRP3 inflammasome
in response to Leishmania infection. Furthermore, we found
that CASP11 also accounts for the production of IL-1a in
response to infection (Figure S2C). The importance of CASP11
for IL-1b production was similarly observed in infections with
L. major (Figure S2D) and L. braziliensis (Figure S2E).
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Furthermore, we investigated whether CASP11 was involved
in CASP1 activation. We infected BMDMs and evaluated
CASP1 activation using FLICA (FAM-YVAD), a cell-permeable
dye that binds to the active form of CASP1. We found that
NLRP3 and CASP11 are required for efficient CASP1 activation
in response to L. amazonensis infection (Figures 2D–2F). Similar
data were obtained when BMDMs were infected with L. major
(Figures S2F–S2H) and L. braziliensis (Figures S2I–S2K). To
further evaluate the effect of CASP11 on CASP1 activation, we
quantified CASP1 activation and secretion in response to infec-
tion using ELISA. We found that CASP11 is required for efficient
CASP1 activation in response to L. amazonensis (Figure 2G).
Using these three different assays, we unequivocally demon-
strate that CASP11 accounts for CASP1 activation and IL-1b
secretion; however, we consistently found a CASP11-indepen-
dent pathway for inflammasome activation in response to infec-
tion. We also evaluated the importance of CASP11 for CASP1
activation using western blot. We found that CASP11 is impor-
tant for CASP1 activation as observed by the production of
CASP1 p20 in response to infection with L. braziliensis,
L. major, and L. amazonensis (Figures S2L and S2M).
Next, we evaluated CASP11 activation directly by pulling
down active CASP11 from infected cells, as previously
described (Cunha et al., 2015). We found that CASP11 is acti-
vated in response to several species of Leishmania, as shown
in the pull-down blot (Figure 2H). The flagellin mutant Legionella
pneumophila (L.p. flaA) triggers potent activation of CASP11
and was used as a positive control in this experiment.
Leishmania LPG Triggers CASP11 Activation in BMDMs,
Resulting in Cell Death and IL-b Release
Parasites from the Leishmania genus display several glycoconju-
gates andproteins that havebeendescribed as virulence factors.
Among those, the most abundant glycoconjugate on the Leish-
mania surface is LPG, which provides a sugar coat that protects
the microbes in different environments, similar to bacterial LPS
(de Assis et al., 2012; Turco and Descoteaux, 1992). CASP11 is
activated by LPS; thus, we hypothesized that LPG could be
involved in CASP11 activation in response to Leishmania spe-
cies. Initially, we compared the production of IL-1b in BMDMs in-
fectedwith L. amazonensis promastigotes or amastigotes, which
highly downregulate LPG expression (de Assis et al., 2012; Turco
and Descoteaux, 1992). We found that whereas promastigotes
induce robust CASP11-dependent inflammasome activation,
the amastigotes induce less potent inflammasome activation
(Figure S3A). Furthermore, we tested the effect of LPG on inflam-
masome activation. C57BL/6 macrophages were transfected
with endotoxin-free highly purified Leishmania LPG. Upon
DOTAP transfection, LPG from L. amazonensis (Figure 3A),
L. major (Figure 3B), and L. donovani (L.d.; Figure 3C) induced
IL-1b production in a dose-dependent manner. E. coli LPS was
used as a positive control (Hagar et al., 2013; Kayagaki et al.,
2013). As expected, no IL-1b was detected when cells were
treated with LPS or LPG in the absence of DOTAP. We found
that LPG transfection also induced CASP1 cleavage as
measured using western blot (Figure 3D). As a control for LPS
contamination in our LPG samples, we quantified endotoxin
levels in purified LPGs using a Limulus amebocyte lysate (LAL)
assay kit, and the concentration of LPS in all samples tested
was below the detection limit (data not shown). In addition, we
evaluated the LPG samples using mass spectrometry and found
that the LPG was free of contamination with polar and non-polar
peptides (data not shown). Next,we transfected LPG inC57BL/6,
Nlrp3–/–, Casp11–/–, and Casp1/11–/– BMDMs and quantified
IL-1b production. We found that L. major, L. amazonensis, and
L. donovani LPG induced robust IL-1b production in C57BL/6
but not in Nlrp3–/–, Casp11–/–, or Casp1/11–/– cells (Figure 3E),
confirming that intracellular LPG triggers CASP11-dependent
activation ofNLRP3.CASP11 activation by LPS inducespore for-
mation in BMDMs (Case et al., 2013; Hagar et al., 2013; Kayagaki
et al., 2013). Thus, we tested if LPG transfection is sufficient to
induce pore formation by assessing the influx of propidium io-
dide. We found that LPG from L. amazonensis, L. major, and
L. donovani induced robust pore formation after 1 hr of transfec-
tion of C57BL/6 macrophages (Figure 3F). NLRP3 was dispens-
able for pore formation induced by LPG, but the pore formation
wasabrogated inCasp11–/– andCasp1/11–/–BMDMs (Figure 3F).
When cell death was measured by assessing LDH release, intra-
cellular (DOTAP-transfected) but not extracellular LPG triggered
cell death as measured by LDH release (Figure 3G). In addition,
LPG from L. amazonensis, L. major, and L. donovani induced
CASP11-dependent cell death upon transfection (Figure 3H).
To further assess the activation of CASP11 by LPG in C57BL/6
macrophages, active CASP11 was pulled down following LPG
transfection. Neither PAM(3)CSK(4) priming alone nor stimulation
with extracellular LPG induced CASP11 activation; however,
transfection of LPG from several Leishmania species resulted in
robust CASP11 activation, closely resembling the activation
induced by LPS (Figure 3I).
It was previously shown that LPS binds directly and activates
mouse CASP11 and human Casp4/5 in vitro (Shi et al., 2014).
Thus, we investigated whether LPG functions similarly to LPS
to induce Casp4 and CASP11 activation. First, we evaluated if
LPGs could activate Casp4 expressed and purified from
insect cells. Although LPS (used as a positive control) induces
strong Casp4 activity, LPG from neither L. amazonensis nor
L. braziliensis could induce Casp4 activation (Figure S3B).
Next, we performed a competition assay using unlabeled LPS
or Leishmania LPGs to compete with biotinylated LPS, as previ-
ously described (Shi et al., 2014). Cell lysates from HEK293T
cells stably expressing Flag-tagged CASP11 (C/A) were first
incubated with unlabeled LPS or LPGs and further incubated
with biotinylated LPS, followed by pull-down with streptavidin
beads. We found that unlabeled LPS, but not LPGs, competed
with biotinylated LPS for CASP11 binding (Figure S3C). Taken
together, these assays show that in a cell-free system, Leish-
mania LPG fails to directly bind or activate human Casp4 or
mouse CASP11, suggesting that the CASP11 activation in
response to Leishmania LPG may be indirect and require addi-
tional molecules present in the macrophage cytoplasm.
A Leishmania major Mutant Lacking LPG (Lpg1–/–) Is
Unable to Trigger the CASP11-Mediated Non-canonical
Activation of the NLRP3 Inflammasome
To evaluate the role of LPG in inflammasome activation during
Leishmania infection, we used an L. major strain deficient for
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LPG (Lpg1–/–). This arose through deletion of all copies of the
Lpg1 gene, which encodes a galactofuranosyl (Galf) transferase
required for biosynthesis of the LPG glycan core (Spa¨th et al.,
2000, 2003). Thus, L. major Lpg1–/– parasites lack LPG but syn-
thesize normal levels of other related glycoconjugates and GPI-
anchored proteins and are a reliable model to evaluate the role of
LPG in the immune response against the parasite (reviewed by
Franco et al., 2012). To evaluate the effect of LPG onCASP1 acti-
vation, BMDMs from C57BL/6, Nlrp3–/–, and Casp11–/– mice
were infectedwith L.majorWTand isogenic controls. The strains
used included Lpg1 null (Lpg1–/–) and Lpg1–/– complemented
with the Lpg1 gene, which generates the add-back strain
(Lpg1–/–/+Lpg1). By performing the FLICA assay, we found that
Lpg1–/– had an impaired ability to trigger CASP1 activation
compared with WT or the complemented strain (Figures 4A–
4C). This effect was fully dependent on NLRP3 and largely
dependent onCASP11.Wemeasured CASP1 p20 usingwestern
blot and found that CASP1 cleavage was decreased in response
Figure 3. Lipophosphoglycan from Leish-
mania spp. Induces Non-canonical Inflam-
masome Activation in Macrophages
(A–C) BMDMs were primed with PAM(3)CSK(4)
(300 ng mL1), transfected with lipophosphoglycan
(LPG) from L. amazonensis (A), L.major (L.m.) (B), or
L. donovani (L.d.) (C) at increasing concentrations
(0.1, 0.5, or 1.0 mg mL1), or treated with LPS. LPG
and LPS (1.0 mg mL1) were also added extracel-
lularly. IL-1b was measured in cell-free superna-
tants using ELISA.
(D) Western blotting indicating the presence of
casp-1 in supernatants (SN) and in the cellular
extract (CE) of BMDMs transfected with different
LPGs or LPS (1 mg mL1).
(E–H) C57BL/6, Nlrp3–/–, Casp11–/–, and Casp1/
11–/– BMDMs were primed with PAM(3)CSK(4) and
transfected with LPG from different Leishmania
species. IL-1b levels were quantified using ELISA
(E), pore formation was assessed fluorometrically in
real time by the uptake of propidium iodide (RFUs
[relative fluorescence units]) (F), and cell death was
evaluated by LDH release (G and H).
(I) Immunoblotting shows the presence of CASP11
p45 and p38 in the cell lysate (input) and its active
form in the pull-down fraction of C57BL/6 BMDMs
transfected with different LPGs. LPG L. braziliensis
(L.b.) was used as an extracellular negative control
and transfected LPS as a positive control. b-Actin
was used as a loading control.
The data are represented as the mean ± SD of
triplicate samples and are representative of the
data obtained from at least three (A–C, E, G, and H)
and two (D, F, and I) independent experiments.
to Lpg1–/– parasites, but this effect was
null in Casp11–/– BMDMs (Figure 4D).
Furthermore, we measured IL-1b using
ELISA and found that IL-1b production
was reduced in response to L. major
Lpg1–/– parasites in C57BL/6 but not
Casp11–/– macrophages (Figures 4E and
4F). This was evident when cells were primed with LPS (Fig-
ure 4E) or PAM(3)CSK(4) (Figure 4F). These effects were not
due to defective internalization of the parasites, as the percent-
age of infected cells (Figure S4A) and the average numbers of
parasites per cell (Figure S4B) were similar between the clones
at 1 hr post-infection.
Next, we performed a pull-down assay in C57BL/6 macro-
phages to evaluate CASP11 activation in response to infection
with L. major Lpg1–/– and Lpg1–/–/+Lpg1. We found that
L. major Lpg1–/– did not trigger robust CASP11 activation in
response to infection (Figure 4G). Finally, we assessed the ef-
fects of LPG and CASP11 in the expression of Nos2, a process
that was previously shown to be dependent on NLRP3 (Lima-
Junior et al., 2013). We infected C57BL/6, Nlrp3–/–, and
Casp11–/– with L. major Lpg1–/– and Lpg1–/–/+Lpg1 and found
that the upregulation of Nos2 but not Tnfa requires LPG,
NLRP3, and CASP11 (Figures 4H and 4I). Taken together these
results demonstrate that Leishmania LPG accounts for
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CASP11 activation and promotes the non-canonical activation of
the NLRP3 inflammasome.
DISCUSSION
Activation of the NLRP3 inflammasome has been reported to
affect the outcome of leishmaniasis in humans and in mouse
models of infection (Charmoy et al., 2016; Gurung et al., 2015;
Lima-Junior et al., 2013, 2017; Novais et al., 2018). We and
others have shown that the inflammasome is protective and ac-
counts for the restriction of parasite replication in macrophages
and in vivo (Lefe`vre et al., 2013; Lima-Junior et al., 2013, 2017;
Miranda et al., 2015; Sani et al., 2014; Santos et al., 2013).
Consistent with this hypothesis, others have shown that certain
Leishmania species actively inhibit activation of the inflamma-
some (Gupta et al., 2017; Hartley et al., 2018; Shio et al.,
2015). However, these findings do not conflict with studies
demonstrating that the inflammasome (via IL-1b) promotes
inflammation and pathology (Charmoy et al., 2016; Dey et al.,
2018; Gurung et al., 2015; Novais et al., 2018; Santos et al.,
2018). It is likely that these two processes occur concomitantly;
while inflammasome-induced inflammation contributes to pa-
thology, it also accounts for induction of protective immunity
that limits parasite replication. Interestingly, it was reported
that the NLRP3 inflammasome contributes to the generation of
CD8+ T cell-mediated cytotoxicity (Charmoy et al., 2016; Dey
et al., 2018; Gurung et al., 2015; Novais et al., 2018; Santos
et al., 2018), an observation that agrees with the vast literature
indicating that adaptive immunity is critical for the outcome of
the disease (reviewed in Broz and Dixit, 2016; Zamboni and
Lima-Junior, 2015). In this context, it is possible that CASP11
also influences the generation of adaptive responses during
leishmaniasis. This hypothesis is particularly supported by the
fact that in vivo phenotypes of the Casp11–/– mice are only
evident after the fourth to fifth week of infection, when adaptive
immunity is well established. Nonetheless, our macrophage ex-
periments unequivocally support a role of CASP11 and NLRP3 in
innate responses that operates in the absence of lymphocytes
and adaptive immunity.
Despite the clear importance of the inflammasome for the
outcomeof disease, little is knownabout themechanismbywhich
NLRP3 is activated during Leishmania infection. ROS production
via dectin-1 and K+ efflux were shown to be involved (Lefe`vre
et al., 2013; Lima-Junior et al., 2013, 2017), but further mecha-
nisms are unknown. Herein, we identified that CASP11 is strongly
activated by Leishmania LPGand leads to the non-canonical acti-
vation of NLRP3. As opposed to LPS, which binds CASP11
directly to induce its activation (Shi et al., 2014), Leishmania LPG
fails to physically interact with CASP11 (or with human Casp4) in
a cell-free system. Nonetheless, transfection of highly purified
Figure 4. LPG Deficiency Impairs Non-ca-
nonical Inflammasome Activation by Leish-
mania major
(A–C) WT, Nlrp3–/–, and Casp11–/– BMDMs were
infected with stationary-phase L. major WT,
L. major Lpg1–/–, or L. major Lpg1–/–/+Lpg1 at an
MOI of 10. Cells were stained for FAM-YVAD and
analyzed using flow cytometry to determine the
percentage of FAM-YVAD-positive cells (B) and
the integrated mean fluorescence intensity (iMFI)
(C). A representative histogram is shown (A).
(D) Western blotting analysis of WT and Casp11–/–
BMDMs infected with L. m. mutants at an MOI
of 10, indicating the presence of casp-1 p45 and
casp-1 p20 in the cell-free culture supernatants
(SN) and casp-1 p45 in the cellular extract (CE).
(E and F) WT and Casp11–/– BMDMs were primed
with LPS (E) or PAM(3)CSK(4) (F) and infected with
stationary-phase L. major WT and mutants at an
MOI of 10. IL-1b levels in cell-free supernatants
were measured using ELISA.
(G) WT BMDMs were primed with PAM(3)CSK(4)
pre-treated with biotin-VAD-FMK and infected
with stationary-phase L. major mutants at an MOI
of 10. The pull-down for active CASP11 was per-
formed as previously described.
(H and I)WT,Nlrp3–/–, andCasp11–/–BMDMswere
infected with stationary-phase L. major Lpg1–/– or
L. major Lpg1–/–/+Lpg1 at an MOI of 10. After 3 hr
of infection, RNA was extracted, and qPCR for the
Nos2 (H) and Tnfa (I) genes were performed.
The data are shown as the mean ± SD of triplicate
samples (A–C, E, and F) and are representative of
data obtained from at least three or two (D and G)
independent experiments. Statistical analysis was
performed using Student’s t test. Asterisks indi-
cate statistically significant differences. *p < 0.05.
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LPG in macrophages (in concentrations equivalent to those used
for LPS) is sufficient to trigger CASP11 activation, suggesting that
additional macrophagemolecules or receptors may participate in
thisprocess. Importantly, LPG-mediatedCASP11activation isnot
due to LPS contamination. Our LPG was purified directly from
Leishmania in endotoxin-free conditions, andwe detected neither
endotoxin nor protein contamination in our LPG preparations. In
addition, a possible LPS contamination in our LPG preparations
would lead to CASP11 activation in the cell-free system experi-
ment, which was not observed (Figure S3). Furthermore, our
experiments with Lpg1–/–, which were all performed in endo-
toxin-free conditions, support our assertion that regardless of
LPS contamination, LPG triggers CASP11 activation. It is worth
mentioning that our experiments using LPG mutant parasites
were performed using an available strain of L. major (Spa¨th
et al., 2000, 2003). Although the effects of the inflammasome in
the outcome of the disease in vivo may be different in L. major
and L. amazonensis, the induction of inflammasome activation in
macrophages is similar in all species tested, including L major
(Charmoy et al., 2016; Gurung et al., 2015; Lima-Junior et al.,
2013, 2017; Novais et al., 2018). These findings support the use
ofL.major Lpg1–/– to assess the effect of CASP11 in the activation
of the NLRP3 inflammasome in macrophages. Of note, experi-
ments in vivo using LPG-deficient parasites cannot be achieved,
because LPG is essential for parasite replication in macrophages
and in vivo. Interestingly, LPG expression is highly down modu-
latedwhen the intracellular parasites become amastigotes (Turco
and Descoteaux, 1992). These findings are in agreement with our
datashowing that axenicamastigotes induce lessCASP11activa-
tion then promastigotes (Figure S3A). One can speculate that this
has been evolutionary selected to limit inflammasome activation
during mammalian infection. Nonetheless, the amastigotes still
express a small amount of LPG (McConville and Blackwell,
1991), a feature that supports our findings that amastigotes still
trigger CASP11-dependent inflammasome activation in macro-
phages (Figure S3A). This may explain our in vivo data, where
we detected an important role for CASP11 after up to 15 weeks
of infection (Figures 1M–1O).
Although LPG was reported to trigger TLR activation, most of
the literature supports an anti-inflammatory role for this mole-
cule (de Assis et al., 2012; Franco et al., 2012; Matte and Desco-
teaux, 2016). Our data indicate that extracellular LPG does not
promote inflammasome activation. However, when LPG is deliv-
ered in the cytosol, it strongly triggers CASP11 activation. It is
unclear if this host response specifically evolved to detect intra-
cellular Leishmania or whether this is actively modulated by
Leishmania to favor disease chronification and transmission. It
is also unclear how LPG accesses the macrophage cytosol to
engage CASP11 activation. It is possible that LPG sheds and
reaches the host cell cytoplasm through the release of exo-
somes before or after macrophage infection (Silverman et al.,
2010). Another possibility is that LPG is actively translocated
to the host cell cytoplasm to promote an inflammatory environ-
ment that, under certain conditions, may favor parasite persis-
tence and transmission (Charmoy et al., 2016; Gurung et al.,
2015; Novais et al., 2018; Santos et al., 2018). Finally, it is also
possible that this glycoconjugate is accidentally translocated
to the host cell cytoplasm during parasite manipulation of
macrophage functions, a process that is still highly underappre-
ciated despite the clinical importance of this disease. Regard-
less of these speculations, our findings link LPG to NLRP3
activation via the CASP11-mediated non-canonical pathway.
These findings help unravel the roles of CASP11 in immunity
and account for our understanding of the pathogenesis and
host response to this important pathogen that infects millions
of people worldwide.
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KEY RESOURCES TABLE
REAGENT OR RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse Anti-Flag Sigma-Aldrich F3165; RRID:AB_259529
Rat Anti-Caspase-1 (clone 4B4) Genentech N/A
Rabbit Anti-Caspase-11 Abcam ab180673
Anti-NLRP3/NALP3 mAb (Cryo-2) AdipoGen Cat# AG-20B-0014; RRID:AB_2490202
Mouse Anti-b-Actin (C4) Santa Cruz sc-47778; RRID:AB_2714189
Chemicals, Peptides and Recombinant proteins
Puromycin Sigma-Aldrich P8833-10MG
Geneticin (G418) Sigma-Aldrich A1720
Hygromycin B InvivoGen ant-hg-1
Pam3CSK4 InvivoGen tlrl-pms
Ultrapure LPS InvivoGen tlrl-3pelps
Biotinylated-LPS InvivoGen Tlrl-3blps
Propidium Iodide Sigma-Aldrich CAS25535-16-4
Mouse TNF-a Recombinat Protein eBioscience 34-8321-63
Lipofectamine 2000 Invitrogen 11668027
DOTAP Roche 11 202 375 001
Ac-WEHD-AFC Enzo Life Sciences ALX-260-117
Biotin-VAD-FMK Cayman Chemicals 1135688-15-1
LIVE/DEAD Violet fluorescent reactive dye Invitrogen L34964
Protease inhibitor cocktail Roche 11 836 153 001
streptavidin-agarose beads Invitrogen SA10004
streptavidin-Sepharose beads Sigma-Aldrich GE17-5113-01
LPG from L. amazonensis This study N/A
LPG from L. major This study N/A
LPG from L. brazilienis This study N/A
Critical commercial assays
Mouse TNF (Mono/Mono) ELISA Set BD Bioscience 555268
Mouse IL-1b/IL-1F2 DuoSet R&D Systems DY401-05
FAM-FLICA Caspase-1 Assay Kit Immunochemistry Technologies 98
Limulus Amebocyte Lysate (LAL) assay kit - QCL-1000 Lonza 50-647U
CytoTox 96 Non-Radioactive Cytotoxicity Assay kit Promega G1780
Caspase-1 (mouse) Elisa Kit Adipogen AG-45B-0002KI01
Experimental Models: Cell Lines
HEK293 ATCC ATCC CRL-1573
L-929 ATCC ATCC CCL-1
Experimental Models: Organism/Strains
C57BL/6J mice Jackson Labs 000664
Caspase-11 Knockout mice Kayagaki et al., 2011 N/A
NLRP3 Knockout mice Mariathasan et al., 2006 N/A
Casp1–/– (Casp1/11–/–/Casp11Tg) Knockout mice Kayagaki et al., 2011 N/A
Leishmania (L.) amazonensis M2269 strain
(MHOM/BR/73/M2269)
Lima-Junior et al., 2013 N/A
Leishmania (L.) amazonensis PH8 strain (IFLA/BR/67/PH8) Lima-Junior et al., 2013 N/A
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact,
Dario S. Zamboni (dszamboni@fmrp.usp.br).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Mouse used in this study were in C57BL/6 genetic background and included C57BL/6 (Jackson Laboratory, stock number 000664),
Nlrp3–/–(Mariathasan et al., 2006), Casp1/11–/–/Casp11Tg (herein called Casp1–/–) (Kayagaki et al., 2011), Casp11–/– (Kayagaki et al.,
2011) and Casp1/11–/– (Kayagaki et al., 2011). Female mice ranging from six- to eight-weeks-old were bred and maintained under
specific pathogen-free conditions at the University of S~ao Paulo, FMRP/USP animal facility. All animals were provided food andwater
ad libitum, at 25C. All experiments were conducted according to the guidelines from the institutional ethical committees for animal
care fromComiss~ao de e´tica emExperimentac¸~ao Animal da Faculdade deMedicina de Ribeir~ao Preto, FMRP/USP, protocol number
14/2016.
Parasite culture and infection in vivo
Leishmania strains used were the following: Leishmania (L.) amazonensis PH8 strain (IFLA/BR/67/PH8), Leishmania (L.) amazonensis
M2269 strain (MHOM/BR/73/M2269), which constitutively expresses GFP (La-GFP), Leishmania (V.) braziliensis M2903
strain (MHOM/BR/75/M2903), Leishmania (L.) major LV39 strain (MRHO/SU/59/P), L. donovani LD4 strain (MHOM/SD/00/1S-
2D),Leishmania (L.) major LV39c5 Lpg1–/– mutant strain (M3P6), Leishmania (L.) major LV39c5 Lpg1–/–/+Lpg1 mutant strain
(M3P4) and Leishmania (L.) infantum (HU-USF 8). L. major Lpg1–/– and L. major Lpg1–/–/+Lpg1 were kept in culture in the presence
of Hygromycin B (15 mgmL1) and Puromycin (10 mgmL1), plus the addition of G418 (Geneticin) (10 mgmL1) for the later. Parasites
were cultured at 25C in Schneider’s Drosophila medium (Invitrogen, Carlsbad, CA), pH 7.0, supplemented with 10% heat-inacti-
vated fetal calf serum (GIBCO BRL), 100 U/ml penicillin G potassium (USB Corporation, Cleveland, OH, USA), 2 mM L-glutamine,
and 2% human urine, pH 6.5. The infective-stage metacyclic promastigotes of L. amazonensiswere isolated from stationary cultures
through density gradient centrifugation, as described previously (Spa¨th et al., 2003). For in vivo infections with L. amazonensis,mice
were infected with either 1 3 106 stationary phase or 1 3 103 metacyclic promastigotes in 10 mL of PBS, through an intradermal in-
jection into the left ear. Ear thicknesses were monitored weekly with a dial gauge caliper and compared to the thickness of the un-
infected contralateral ear. Parasite burdens were determined in the ear and retromaxilar lymph node, which drains the site of
infection.
Continued
REAGENT OR RESOURCE SOURCE IDENTIFIER
Leishmania (V.) braziliensis M2903 strain
(MHOM/BR/75/M2903)
Lima-Junior et al., 2013 N/A
Leishmania (L.) major LV39 strain (MRHO/SU/59/P Lima-Junior et al., 2013 N/A
Leishmania (L.) major LV39c5 Lpg1/ mutant strain (M3P6) Spa¨th et al., 2000 N/A
Leishmania (L.) major LV39c5 Lpg1//+Lpg1 mutant
strain (M3P4)
Spa¨th et al., 2000 N/A
Leishmania (L.) infantum (HU-USF 8) Lima-Junior et al., 2013 N/A
Oligonucleotides
HPRT forward Lima-Junior et al., 2013 TCAGTCAACGGGGGACATAAA
HPRT reverse Lima-Junior et al., 2013 AAGCCATGCCAATGTTGTCT
Nos2 forward Lima-Junior et al., 2013 CGAAACGCTYCACTTCCAA
Nos2 reverse Lima-Junior et al., 2013 CGAAACGCTYCACTTCCAA
Tnfa forward Lima-Junior et al., 2013 TGTGCTCAGAGCTTTCAACAA
Tnfa reverse Lima-Junior et al., 2013 CTTGATGGTGGTGCATGAGA
Software and Algorithms
FlowJo Tree Star software FlowJo LLC https://www.flowjo.com/solutions/
flowjo/downloads
GraphPad Prism 7.0 GraphPad Software https://www.graphpad.com/scientific-
software/prism/
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METHOD DETAILS
Extraction and purification of LPG
Late log phase cells were harvested and washed twice with PBS prior to LPG extraction with solvent E (H2O/ethanol/diethylether/
pyridine/ NH4OH; 15:15:5:1:0.017). For purification, the solvent E extract was dried under N2 evaporation, resuspendend in 2 mL
of 0.1 N acetic acid/0.1 M NaCl, and subjected to hydrophobic chromatography using a column of phenyl-Sepharose. The column
was sequentially washed with 6 mL of 0.1N acetic acid/0.1 M NaCl, 1 mL of 0.1 N acetic acid and 1 mL of endotoxin free water. The
LPG was eluted with 4 mL of solvent E then dried under N2 evaporation. LPG concentration was determined using the phenol-sul-
phuric method. All solutions were prepared in sterile, LPS-free distilled water (Sanobiol, Campinas, Brazil).
Bone marrow-derived macrophages and infection
Isolated femurs and tibia were flushed with incomplete RPMI, and the precursor cells were cultured in RPMI supplemented with 30%
L929 cell-conditionedmedium and 20%FBS. After 7 days in culture, themature BMDMswere harvested and infected with stationary
phase promastigotes at MOI 3, 5 or 10, depending on the Leishmania (indicated in figure legends). In killing experiments, free par-
asites were washed, and fresh media was added to the infected cultures after 1h of infection, and the parasite load was determined
at 1, 48 and 96h post-infection via flow cytometric and Giemsa staining, using a FACS ACCURI C6 flow cytometer (BD Biosciences)
and counting the Giemsa-stained cytospin preparations under a light microscope with a 100X objective, respectively. For flow cyto-
metric analysis, cells were infected at different MOIs, and in the end of each time point, detached from the plate (without fixation)
using trypsin, stained with LIVE/DEAD and analyzed. The flow cytometric data were analyzed using the FlowJo software (Tree
Star). In this analysis, two parameters were considered: the percentage of infected cells and the integrated MFI (iMFI), which reflects
the total functional response toward the infection and is calculated by themultiplication of the percentage of infected cells by theMFI.
InGiemsa staining analysis, the infection rate was determined by scoring the% of infected macrophages (100 BMDMs counted) and
the average number of intracellular parasites per cell.
Transfection experiments
Fully differentiated BMDMswere transfected with LPS (InvivoGen) (1 mgmL1) or highly purified LPGs from different Leishmania spe-
cies. Cells were transfected with DOTAP Liposomal Transfection Reagent (Roche) or Lipofectamin 2000 reagent (Invitrogen) in RPMI
(GIBCO) 1% FBS medium, according to manufacturer’s instructions.
Cell death assay
Cells were transfected in phenol red-free RPMI medium for the indicated times, and then supernatants were collected and cell death
was measured by the LDH release assay using the CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega). The values ob-
tained are represented as percentage (%) compared to cell death induced by detergent lysis (3% Triton X-100).
Membrane pore formation assay
Kinetics of pore formation in BMDMs was quantified by the permeability to propidium iodide (PI) and its uptake by damaged cells.
BMDMswere seeded in a black, clear-bottom 96-well plate, and before stimulation with LPG, BMDMswere washed with warm PBS,
and themediawere replenishedwith RPMI 10%FBSwithout phenol red, 0.038 gmL1 NaHCO3, and 6mgmL1 PI. Infected BMDMs
were kept at 37C, and PI was excited at 538 nm. The fluorescence emission was read at 617 nm in 5 min intervals using a plate
fluorometer (SpectraMax, Molecular Devices). The values obtained are represented as percentage (%) compared to cell death
induced by detergent lysis (TritonX).
Endotoxin detection
The levels of endotoxin (LPS) were quantified by Limulus Amebocyte Lysate (LAL) assay kit (Lonza) in all highly pure LPG samples
used in this study, according to manufacturer’s instructions.
ROS detection
BMDMswere infected with stationary-phase promastigotes of L. amazonensis at anMOI of 10 or stimulated with PMA (200 ng/ml) for
90 min. Then, H2DCFDA (10 mM) was added to the cells for 30 min at 37C. The cells were harvested and immediately analyzed by
flow cytometry.
In vivo detection of CASP1
C57BL/6, Nlrp3–/– and Casp11–/– mice were injected with vehicle (PBS) or 106 L. amazonensis stationary-phase parasites. After
2 weeks of infection, the injected ears were removed, digested and macerated in collagenase. The macerate’s supernatants were
collected to measure CASP1 levels using CASP1 (mouse) ELISA KIT (Adipogen).
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ELISA assay
The IL-1b, IL-1a and TNF-a production was assessed using IL-1b, IL-1a and TNF-a (BD Biosciences) ELISA KIT. CASP1 was
measured using CASP1 (mouse) ELISA KIT (Adipogen). In vitro IL-1b production was analyzed in the cell-free supernatants harvested
from the BMDMs pre-stimulated with 500 ng/ml of ultrapure LPS (InvivoGen), 10 ng/ml of TNF-a (eBioscience) or 300 ng/mL of
PAM(3)CSK(4) (InvivoGen) for 4 hours and subsequently infected with stationary phase promastigotes at different MOI.
Endogenous CASP1 staining
The BMDMs were cultured and infected with stationary phase Leishmania at MOI 10. After 24 hours of infection, BMDMs were
stained for 1 h with FAM–YVAD–fluoromethyl ketone (FAM–YVAD–FMK; Immunochemistry Technologies), as recommended by
the manufacturer’s instructions. The active CASP1 was then measured by flow cytometry. The data were acquired on a FACS
ACCURI C6 flow cytometer (BD Biosciences) and analyzed with the FlowJo software (Tree Star).
Western blot
A total of 5 3 106 BMDMs were seeded per well, primed with ultrapure LPS (500 ng/ml) for 4 h and then infected with the different
Leishmania species for 24 hours. The supernatants were collected and precipitated with 50% trichloroacetic acid and acetone. After
their clarification by centrifugation, the cells were lysed in RIPA buffer (10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 150 mMNaCl, 1% Non-
idet P-40, 1% deoxycholate, and 0.1% SDS) containing protease inhibitor cocktail (Roche). The lysates and supernatants were re-
suspended in Laemmli buffer, boiled, resolved by SDS-PAGE and transferred (Semidry Transfer Cell, Bio-Rad) to a nitrocellulose
membrane (GE Healthcare). The membranes were blocked in Tris-buffered saline (TBS) with 0.01% Tween-20 and 5% non-fat
dry milk. The rat anti- CASP1 p20 monoclonal antibody clone 4B4 (Genentech) (1:500) and specific anti-rat horseradish peroxi-
dase-conjugated antibodies (1:3000; KPL) were diluted in blocking buffer for the incubations. The ECL luminol reagent (GE Health-
care) was used for the antibody detection.
Casp4 activity assay
The Casp4 activity assay was performed as previously described (Shi et al., 2014). Briefly, each ligand was incubated with 0.15 mMof
recombinant Casp4 protein, expressed in insect cells, in a buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 3 mM EDTA,
0.005% (v/v) Tween-20 and 10 mM DTT. After 30 min at 30C, the Casp4 substrate Ac-WEHD-AFC was added into a reaction at
a final concentration of 100 mM. The reaction mixtures were transferred to a 384-well plate and incubate at 37C for another
30 min. Substrate cleavage was monitored by measuring the emission at 505 nm on excitation at 400 nm on a fluorescent multi-
well reader (PerkinElmer Enpire Multimode Plate Reader).
Active CASP11 and LPG binding pull-down assay
For active CASP11 pull-down, primed BMDMs were replenished with fresh media containing 20 mM biotin-VAD-FMK (Enzo)
15 min before infection. Infected BMDMs were lysed in RIPA buffer (10mM Tris-HCl (pH 7.4), 1mM EDTA, 150mM NaCl, 1% Non-
idet P-40, 1% (w/v) sodium deoxycholate and 0.1% (w/v) SDS) supplemented with protease inhibitor cocktail (Roche). Cleared
lysates were equalized according to total protein content, incubated overnight with streptavidin-agarose beads (Invitrogen) and
thoroughly rinsed with RIPA buffer. Bound proteins were eluted by re-suspension in Laemmli sample buffer, boiled for 5min
and separated by SDS–polyacrylamide gel electrophoresis. LPG binding to CASP11 was performed as previously described
for LPS binding (Shi et al., 2014). Briefly, Flag-tagged CASP11 was stable expressed in 293T cells and lysed in a buffer contaning
50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% Triton X-100 and protease inhibitor cocktail. One mg of Biotin-conjugated LPS was
first immobilized onto 10 mL of streptavidin Sepharose beads for each reaction. Cell lysate was pre-cleared with streptavidin Se-
pharose beads and 20 mg of unlabled LPS, LPG L. braziliensis or LPG L. major were incubated with pre-cleared lysates for 60 min
at 4C in constant rotation, and then biotinylated LPS-conjugated with streptavidin beads were added to the cell lysate for 90 min
at 4C. Beads were washed with lysis buffer for three times and boiled in 1X SDS sample loading buffer followed by Immunoblot-
ting analyses.
Real-time PCR
Total RNA was extracted from 13 106 Leishmania-infected BMDMs (MOI 10) using TRIzol reagent (Invitrogen). Contaminating DNA
was removed with an RNase-free DNase set (Promega). cDNA was synthesized from 1 mg of RNA using the SuperScript II reverse
transcriptase (Invitrogen). Subsequent real-time PCR was performed on an AI PRISM 7000 sequence detector (Applied Biosystems)
using SYBR Green (Invitrogen). The following primer sequences were used: HPRT forward (50- TCAGTCAACGGGGGACATAAA-30),
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reverse (50-AAGCCATGCCAATGTTGTCT-30), Tnfa forward (50-TGTGCTCAGAGCTTTCAACAA-30), reverse (50-CTTGATGGTGGTG
CATGAGA-30) and Nos2 forward (50-CGAAACGCTYCACTTCCAA-30), reverse (50- GGGGCTGTACTGCTTAACCAG 30).
The mRNA expression levels were normalized to HPRT. The adjusted values were calculated using the following formula:
2(CT target  CTHPRT), where CT is the cycle threshold. The fold change in the expression was calculated as the n-fold difference in
expression in the infected cells compared to the uninfected cells.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
For the comparison of multiple groups, two-way analysis of variance (ANOVA), followed by the Bonferroni post-test were used. The
differences in the values obtained for two different groups were determined using an unpaired, two-tailed Student’s t test with a 95%
confidence interval. Analyses were performed using the Prism 5.0 software (GraphPad, San Diego, CA). A difference was considered
statistically significant when p% 0.05.
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Figure S1. Caspase-11 is important for controlling Leishmania spp. infection in vitro and in vivo. 
Related to Figure 1. 
(A) Representative flow cytometry analysis of the killing assay performed in non-infected (NI) WT 
BMDMs or infected with either the WHO standard strain of L.a. (PH8), or L.a. constitutively expressing 
GFP. Cells were initially gated to exclude debris (SSC-A/FSC-A) and doublets (FSC-A/FSC-H), dead 
	  	  
cells were excluded (FSC-H/LiveDead), and live BMDMs were gated on the FITC channel. NI and L.a. 
PH8-infected cells are demonstrated as controls for BMDMs and parasite autofluorescence, respectively. 
(B) C57BL/6, Nlrp3-/- and Casp11-/- BMDMs were infected with stationary-phase L. amazonensis at a 
MOI of 10. After 6 hours of infection, RNA was extracted, and qPCR for the Nos2 gene was performed. 
(C) C57BL/6, Nlrp3-/- and Casp11-/- BMDMs were infected for 2 hours with stationary-phase L. 
amazonensis at a MOI of 10 or stimulated with PMA as a positive control (50 ng/mL). Thirty minutes 
before the end of the infection, a fluorescent dye to stain total ROS was added. Cells were harvested and 
analyzed by FACS. 
(D) C57BL/6, Nlrp3-/- and Casp11-/- BMDMs were infected with stationary-phase L. amazonensis at a 
MOI of 10. After 24 hours of infection, cell lysates were obtained, and a western blot was performed to 
evaluate the expression of NLRP3. β-actin was used as a loading control. 
(E-H) C57BL/6, Nlrp3-/-, Casp11-/- and Casp1/11-/- mice were infected in the ear dermis with 106 
stationary phase L. amazonensis (E, F) promastigotes. Ear thickness was measured by subtracting the size 
of the uninfected ear from the infected ear and was monitored weekly after infection for a total of 8 
weeks. The parasite burdens in the infected ear (F, H) were measured at 8 weeks post-infection using 
limiting dilution analysis. The data are represented as the means ± SD of 4 mice per group and are 
representative of the data obtained from two independent experiments. 
(G) C57BL/6, Nlrp3-/- and Casp11-/- mice were injected with PBS or 106 Stationary-phase promastigotes. 
After 2 weeks, ears were removed and caspase-1 levels were measured by ELISA. 
Data are represented as the means ± SD of at least triplicate samples and are representative of the data 
obtained from at least two independent experiments (A-D,I). Asterisks (*) indicate significant differences 
(P < 0.05) between indicated groups (D), whereas * and # (E,F) indicate significant differences (P < 0.05) 
between C57BL/6 and casp11-/- or casp11 and casp1/11-/- mice, respectively.   
  
	  	  
 
 
 
Figure S2. Non-canonical inflammasome is activated by different Leishmania species. Related to 
Figure 2. 
	  	  
(A, B) C57BL/6, Nlrp3-/- and Casp11-/- BMDMs were primed with PAM(3)CSK(4) (300 ng mL-1) (A) or 
LPS (500 ng mL-1) (B) and infected with stationary phase Leishmania amazonensis promastigotes at a 
MOI of 10. Levels of IL-1β were measured by ELISA at 1, 24, 48, 72 and 96 h post-infection. 
(C) WT, Casp1/11-/- and Casp11-/- BMDMs were primed for 4 hours with LPS (500 ng mL-1) and then 
infected or not (NI) with L.a. and L.m. Levels of IL-1α were measured by ELISA. 
(D, E) WT and Casp11-/- BMDMs were stimulated for 4 hours with LPS (500 ng mL-1) and then infected 
or not (NI) with L.m. (D) or L.b. (E). Levels of IL-1β were measured by ELISA. 
(F-K) C57BL/6, Nlrp3-/- and Casp11-/- BMDMs were infected with stationary phase Leishmania 
promastigotes at a MOI of 10. After 24 hours of infection with L. major (L.m.) (F-H) or L. braziliensis 
(L.b.) (I-K), cells were stained for FAM-YVAD and analyzed by flow cytometry to determine the 
percentages of FAM-YVAD-positive cells (G, J) and the integrated mean fluorescence intensity (iMFI) 
(H, K). A representative histogram is also shown (F,I).  
(L, M) Western blotting indicating the presence of casp-1 p45 and casp-1 p20 in the cell-free culture 
supernatants (SN) and casp-1 p45 in the cellular extract (CE) upon infection with L. braziliensis (L.b.) 
and L. major. (L.m.) (L) or L. amazonensis (L.a.) (M). 
The data are represented as the means ± SD of triplicate samples and are representative of at least two 
independent experiments. Statistical analysis was performed by two-way ANOVA with Bonferroni’s 
multiple comparison test. Asterisks indicate statistically significant differences. 
  
	  	  
 
 
Figure S3.  Leishmania lypophosphoglycan does not bind to human caspase-4 or mouse caspase-11. 
Related to Figure 3.  
(A) C57BL/6, Nlrp3-/- and Casp11-/- BMDMs were primed with LPS (500 ng mL-1) and infected with 
stationary phase Leishmania amazonensis promastigotes or Leishmania amazonensis amastigotes at a 
MOI of 5. Levels of IL-1β were measured by ELISA. 
(B) Recombinant Caspase-4 purified from insect cells was incubated with H2O, LPS, LPS + zVAD, LPG 
L.b. or LPG L.m. in the presence of the Caspase-4 substrate Ac-WEHD-FC (100 µM). Substrate cleavage 
was monitored by measuring the emission at 505 nm.  
(C) 293T cells were transfected with Flag-tagged Caspase-11 (C/A), and cell lysates were first incubated 
with unlabeled LPS, LPG L.b. or LPG L.m. and after incubation with biotin-conjugated LPS. Streptavidin 
sepharose beads were used to pull-down Caspase-11. Pull-down was probed with anti-Flag, and the Input 
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was probed with anti-Flag and anti-α-tubulin. The data are represented as the means ± SD of triplicate 
samples and are representative of two (A, C) and three (B) independent experiments. Statistical analysis 
was performed using an unpaired, two-tailed Student’s t test.  Asterisks indicate statistically significant 
differences.  
  
	  	  
 
 
 
 
Figure S4. L. major internalization is not affected in the absence of LPG. Related to Figure 4. 
(A, B) WT and Casp11-/- BMDMs were infected with stationary phase L. m. WT, L. m. Lpg1-/- or L. m. 
Lpg1-/-/+Lpg1 at a MOI of 3. After 1 hour of infection, cells were washed and stained by Giemsa. The 
percentage of infected cells (A) and the average number of parasites per cell were calculated (B). The data 
are represented as the means ± SD of triplicate samples and are representative of the data obtained from 
two independent experiments.  
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